Difference between skin toxicities in erlotinib (E) and gefitinib (G) in the treatment of advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Defferrari, C. [1 ]
Loprevite, M. [1 ]
Brianti, A. [1 ]
Catania, G. [1 ]
Grossi, F. [1 ]
Pronzato, P. [1 ]
机构：
[1] Natl Inst Canc Res, Genoa, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18187
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Gefitinib and Afatinib Treatment in an Advanced Non-small Cell Lung Cancer (NSCLC) Patient Undergoing Hemodialysis
    Bersanelli, Melissa
    Tiseo, Marcello
    Artioli, Fabrizio
    Lucchi, Leonardo
    Ardizzoni, Andrea
    [J]. ANTICANCER RESEARCH, 2014, 34 (06) : 3185 - 3188
  • [22] The results of the treatment with gefitinib (Iressa) in 89 patients with advanced non-small cell lung cancer (NSCLC)
    Skrickova, J
    Tomiskova, M
    Svobodnik, A
    Kaplanova, J
    Kadlec, B
    Palkova, I
    Babickova, L
    Stratil, D
    Nebesky, T
    [J]. LUNG CANCER, 2005, 49 : S376 - S376
  • [23] Comparison of Skin Toxic Effects Associated With Gefitinib, Erlotinib, or Afatinib Treatment for Non-Small Cell Lung Cancer
    Chen, Kai-Lung
    Lin, Chia-Chi
    Cho, Yung-Tsu
    Yang, Che-Wen
    Sheen, Yi-Shuan
    Tsai, Hsiao-En
    Chu, Chia-Yu
    [J]. JAMA DERMATOLOGY, 2016, 152 (03) : 340 - 342
  • [24] Review of erlotinib in the treatment of advanced non-small cell lung cancer
    Ganjoo, Kristen N.
    Wakelee, Heather
    [J]. BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 335 - 346
  • [25] Successful treatment with erlotinib of severe neutropenia induced by gefitinib in a patient with advanced non-small cell lung cancer
    Araya, Tomoyuki
    Kasahara, Kazuo
    Demura, Yoshiki
    Matsuoka, Hiroki
    Nishitsuji, Masaru
    Nishi, Koichi
    [J]. LUNG CANCER, 2013, 80 (03) : 344 - 346
  • [26] ERLOTINIB AND BEXAROTENE FOR PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Dragnev, K. H.
    Seltzer, M.
    Rigas, J. R.
    DiSalvo, W. M.
    Simeone, S.
    Johnstone, D.
    Nugent, W.
    Waxman, S.
    Dmitrovsky, E.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
  • [27] Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib
    Vasile, Enrico
    Tibaldi, Carmelo
    Chella, Antonio
    Falcone, Alfredo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 912 - 914
  • [28] META-ANALYSIS OF RELATIONSHIP BETWEEN SKIN RASH AND OUTCOME IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH ERLOTINIB (E) AND GEFITINIB (G)
    Borgonovo, K. F.
    Petrelli, F.
    Cabiddu, M.
    Ghilardi, M.
    Cremonesi, M.
    Maspero, F.
    Barni, S.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 435 - 435
  • [29] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [30] Gefitinib in advanced non-small cell lung cancer
    Sharma, R
    Boyer, M
    Clarke, S
    Millward, M
    [J]. INTERNAL MEDICINE JOURNAL, 2005, 35 (02) : 77 - 82
12345